Mesoblast Limited (MESO) Q2 2026 Earnings Call Transcript
Source: SeekingAlpha
2026-02-27 02:27:52 ET
Mesoblast Limited (MESO) Q2 2026 Earnings Call February 26, 2026 5:00 PM EST
Company Participants
Paul Hughes - Joint Company Secretary
Silviu Itescu - Founder, CEO, MD, Chairman of Scientific Advisory Board & Executive Director
James O’Brien - Chief Financial Officer
Marcelo Santoro - Chief Commercial Officer
...
Read the full article on Seeking Alpha
For further details see:
Mesoblast Limited (MESO) Q2 2026 Earnings Call Transcript
Mesoblast Limited
NASDAQ: MESO
MESO Trading
3.47% G/L:
$15.655 Last:
18,019 Volume:
$15.51 Open:
MESO Latest News
March 03, 2026 10:02:00 am
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them
MESO Stock Data
$2,320,216,937
94,873,961
N/A
31
N/A
Biotechnology & Life Sciences
Healthcare
AU
Melbourne
